Sangamo BioSciences | SGMO - Market Capitalization


Sangamo BioSciences reported $35.4M in Market Capitalization this May of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Alaunos Therapeutics USD 5M 5M Sep/2025
Alnylam Pharmaceuticals USD 44.15B 8.39B Mar/2026
Alterity Therapeutics Limited AUD 40M 16M May/2026
Amgen USD 189.89B 13.64B Mar/2026
Bayer EUR 37.69B 1.01B May/2026
BioCryst Pharmaceuticals USD 1.66B 64M Dec/2025
Biogen USD 26.9B 1.09B Mar/2026
BioMarin Pharmaceutical USD 10.18B 683M May/2026
Cipla INR 1.15T 162.77B May/2026
Clal Biotechnology ILS 43.45M 8.92M Mar/2026
Compugen USD 144.67M 7.17M Dec/2025
CSL USD 55.89B 20.42B Dec/2025
Gilead Sciences USD 167.39B 5.6B May/2026
GlaxoSmithKline GBP 83.8B 9.44B Mar/2026
Ionis Pharmaceuticals USD 12.46B 356M Mar/2026
J&J USD 579.15B 78.91B Mar/2026
Karyopharm Therapeutics USD 956M 821M May/2026
Merck USD 297.1B 35.84B Mar/2026
Novartis USD 232.75B 75B May/2026
Pfizer USD 147.4B 6.42B May/2026
Roche Holding CHF 266.34B 55.46B Dec/2025
Sanofi EUR 100.27B 605.48M Mar/2026
Sarepta Therapeutics USD 2.16B 123M May/2026
Tectonic Therapeutic USD 390M 96M Dec/2025
Ultragenyx Pharmaceutical USD 2.06B 1000K May/2026
Vertex Pharmaceuticals USD 113.58B 1000K May/2026